1204 related articles for article (PubMed ID: 20697077)
1. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
[TBL] [Abstract][Full Text] [Related]
2. Cancer therapy costs influence treatment: a national survey of oncologists.
Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P
Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377
[TBL] [Abstract][Full Text] [Related]
3. Do oncologists believe new cancer drugs offer good value?
Nadler E; Eckert B; Neumann PJ
Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
[TBL] [Abstract][Full Text] [Related]
4. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
5. Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians.
de Kort SJ; Kenny N; van Dijk P; Gevers S; Richel DJ; Willems DL
Eur J Cancer; 2007 Sep; 43(13):1983-9. PubMed ID: 17616456
[TBL] [Abstract][Full Text] [Related]
6. How physicians react to cost-effectiveness information.
Asch DA
LDI Issue Brief; 2003; 8(9):1-4. PubMed ID: 12956120
[TBL] [Abstract][Full Text] [Related]
7. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
8. European perspective on the costs and cost-effectiveness of cancer therapies.
Drummond MF; Mason AR
J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
[TBL] [Abstract][Full Text] [Related]
9. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors.
Quinn GP; Vadaparampil ST; Lee JH; Jacobsen PB; Bepler G; Lancaster J; Keefe DL; Albrecht TL
J Clin Oncol; 2009 Dec; 27(35):5952-7. PubMed ID: 19826115
[TBL] [Abstract][Full Text] [Related]
10. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
11. United healthcare, five oncology practices try bundled payments.
Goozner M
J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
[No Abstract] [Full Text] [Related]
12. Oral oncolytics: Part 2--legislation targeting cost & access, and other initiatives to reduce costs.
Mancini R; McBride A; Kruczynski M
Oncology (Williston Park); 2013 Sep; 27(9):865-6, 871. PubMed ID: 24282981
[No Abstract] [Full Text] [Related]
13. Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs.
Daroudi R; Mirzania M; Zendehdel K
Int J Health Policy Manag; 2015 Oct; 5(2):99-105. PubMed ID: 26927395
[TBL] [Abstract][Full Text] [Related]
14. Inequities in access to medical care in five countries: findings from the 2001 Commonwealth Fund International Health Policy Survey.
Schoen C; Doty MM
Health Policy; 2004 Mar; 67(3):309-22. PubMed ID: 15036818
[TBL] [Abstract][Full Text] [Related]
15. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer.
Spill GR; Hlubocky FJ; Daugherty CK
PM R; 2012 Feb; 4(2):96-108. PubMed ID: 22373458
[TBL] [Abstract][Full Text] [Related]
16. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
17. Self-reported practices and attitudes of US oncologists regarding off-protocol therapy.
Peppercorn J; Burstein H; Miller FG; Winer E; Joffe S
J Clin Oncol; 2008 Dec; 26(36):5994-6000. PubMed ID: 19029413
[TBL] [Abstract][Full Text] [Related]
18. Physicians' perspectives on caring for patients in the United States, Canada, and West Germany.
Blendon RJ; Donelan K; Leitman R; Epstein A; Cantor JC; Cohen AB; Morrison I; Moloney T; Koeck C; Levitt SW
N Engl J Med; 1993 Apr; 328(14):1011-6. PubMed ID: 8450854
[TBL] [Abstract][Full Text] [Related]
19. An analysis of health system reform for dermatologists: elements and implications of the Patient Protection and Affordable Care Act.
Resneck JS
J Am Acad Dermatol; 2010 Oct; 63(4):706-15. PubMed ID: 20708300
[TBL] [Abstract][Full Text] [Related]
20. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs.
Shrank WH; Asch SM; Joseph GJ; Young HN; Ettner SL; Kholodenko Y; Glassman P; Kravitz RL
Ann Pharmacother; 2006 Sep; 40(9):1534-40. PubMed ID: 16912246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
